Differences in care were most prominent when centers with a high proportion of minority patients were compared with the quality outcomes of white patients.
Feeds
54593 items (54593 unread) in 74 feeds
Acinar Cell Carcinoma
(336 unread)
Acinic Cell Carcinoma
(249 unread)
Adenoid Cystic Carcinoma
(1041 unread)
Adrenal Gland Cancer
(4874 unread)
Ampulla Of Vater
(1142 unread)
Anal Cancer
(5328 unread)
Angiosarcoma
(1620 unread)
Appendix Cancer
(780 unread)
Bile Duct Cancer
(7002 unread)
Brain and CNS
(7238 unread)
Carcinoid
(2310 unread)
Endocrine/Neuroendocrine
(5760 unread)
Gall Bladder Cancer
(2522 unread)
Hemangioendothelioma
(787 unread)
Hepatoblastoma
(761 unread)
Pancreas
(751 unread)
Phyllodes
(416 unread)
PMP and Mucinous Tumors
(472 unread)
Rhabdomyosarcoma
(2152 unread)
Sarcoma
(9052 unread)
Google - Ampullary Cancer
-
Quality of End-of-Life Care Found to Be Worse at Cancer Centers Serving Minority Populations - Cancer Therapy Advisor
Posted: June 1st, 2019, 5:00am GMT
Quality of End-of-Life Care Found to Be Worse at Cancer Centers Serving Minority Populations Cancer Therapy Advisor